多病共存老年人潜在不适当处方的性别差异
结果显示女性PIM处方率高于男性(39.4% vs 32.8%),总体PIM校正OR为1.30(95%CI 1.16-1.46),且性别差异因多病模式和PIM药物类别而异。
要点
- 女性PIM处方率高于男性(39.4% vs 32.8%),总体校正OR=1.30(95%CI 1.16-1.46)。
- 心血管代谢合并躯体疾病模式及合并精神疾病模式下,女性PIM风险均升高(校正OR=1.25)。
- 女性抗胆碱能药、抗抑郁药、解痉药、苯二氮䓬类、骨骼肌松弛剂处方风险更高,镇痛药和磺脲类风险更低。
核心结论
- 女性多病共存老年人PIM处方风险总体高于男性,且性别效应因多病模式和药物类别而异。
研究设计与样本
- 回顾性队列研究,使用HRS 2004-2014年访谈数据链接HRS-Medicare理赔数据(2005-2014年度化)。
主要发现
- 女性PIM处方率39.4%,男性32.8%。
- 总体女性PIM校正OR=1.30(95%CI 1.16-1.46)。
- 心血管代谢合并躯体疾病模式校正OR=1.25(95%CI 1.07-1.45),心血管代谢合并精神疾病模式校正OR=1.25(95%CI 1.06-1.48)。
- 单纯心血管代谢疾病模式性别差异无统计学意义(校正OR=1.13,95%CI 0.79-1.62)。
- 女性抗胆碱能药、抗抑郁药、解痉药、苯二氮䓬类、骨骼肌松弛剂处方风险更高,镇痛药和磺脲类风险更低。
关键数值与推荐
- PIM事件依据2015年美国老年医学会Beers标准计算。
- 多病模式分为:单纯心血管代谢疾病、心血管代谢合并其他躯体疾病、心血管代谢合并精神疾病、无心血管代谢疾病。
临床怎么用
- 对多病共存老年女性,尤其合并躯体或精神疾病模式者,应加强PIM处方审核。
- 关注女性中抗胆碱能药、抗抑郁药、解痉药、苯二氮䓬类、骨骼肌松弛剂等PIM高风险药物类别。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: Limited knowledge exists regarding sex differences in prescribing potentially inappropriate medications (PIMs) for various multimorbidity patterns. This study sought to determine sex differences in PIM prescribing in older adults with cardiovascular-metabolic patterns. DESIGN: Retrospective cohort study. SETTING: Health and Retirement Study (HRS) 2004-2014 interview data, linked to HRS-Medicare claims data annualized for 2005-2014. STUDY SAMPLE: Six thousand three-hundred and forty-one HRS participants aged 65 and older with two and more chronic conditions. MEASUREMENTS: PIM events were calculated using 2015 American Geriatrics Society Beers Criteria. Multimorbidity patterns included: "cardiovascular-metabolic only," "cardiovascular-metabolic plus other physical conditions," "cardiovascular-metabolic plus mental conditions," and "no cardiovascular-metabolic disease" patterns. Logistic regression models were used to determine the association between PIM and sex, including interaction between sex and multimorbidity categories in the model, for PIM overall and for each PIM drug class. RESULTS: Women were prescribed PIMs more often than men (39.4% vs 32.8%). Overall, women had increased odds of PIM (Adj. odds ratio [OR] = 1.30, 95% confidence interval [CI]: 1.16-1.46). Women had higher odds of PIM than men with cardiovascular-metabolic plus physical patterns (Adj. OR = 1.25, 95% CI: 1.07-1.45) and cardiovascular-metabolic plus mental patterns (Adj. OR = 1.25, 95% CI: 1.06-1.48), and there were no sex differences in adults with a cardiovascular-metabolic only patterns (Adj. OR = 1.13, 95% CI: 0.79-1.62). Women had greater odds of being prescribed the following PIMs: anticholinergics, antidepressants, antispasmodics, benzodiazepines, skeletal muscle relaxants, and had lower odds of being prescribed pain drugs and sulfonylureas compared with men. CONCLUSION: This study evaluated sex differences in PIM prescribing among adults with complex cardiovascular-metabolic multimorbidity patterns. The effect of sex varied across multimorbidity patterns and by different PIM drug classes. This study identified important opportunities for future interventions to improve medication prescribing among older adults at risk for PIM.
引用
- Ukhanova M, Markwardt S, Furuno JP, et al. Are there sex differences in potentially inappropriate prescribing in adults with multimorbidity? J Am Geriatr Soc. 2021. PMID: 33959939. doi:10.1111/jgs.17194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。